Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2000

01-12-2000 | Paper Report

A transcription factor compelling Th1 differentiation

Author: Christian Schneider

Published in: Arthritis Research & Therapy | Issue 1/2000

Login to get access

Excerpt

Upon activation, Thp cells differentiate into at least two distinct subsets. Th1 cells bias the immune response towards cell-mediated immunity and activate macrophages. Th2 cells mediate humoral immune responses, activate B cells and downregulate macrophage activation. The hallmark of Th1 and Th2 dichotomy is the distinct pattern of cytokines that drive the effector functions associated with the respective subsets. Th1 cells produce TNF-?, IL-2 and IFN-?, whereas Th2 cells secrete IL-4, IL-5, and IL-9. Much interest has focused on genes that are involved in directing the differentiation of uncommitted Thp cells towards Th1 or Th2 effectors. Some progress has been made in elucidating the genetic control of Th2 development, and TFs specific for Th2 cells have been described, eg c-Maf and GATA-3. However, little is known about the genetic factors driving Th1 development. To find Th1-restricted TFs that control Th1-specific cytokine gene transcription, and to study the influence of TF expression in developing Th2 cells. …
Literature
1.
go back to reference Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000, 100: 655-669.PubMedCrossRef Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000, 100: 655-669.PubMedCrossRef
Metadata
Title
A transcription factor compelling Th1 differentiation
Author
Christian Schneider
Publication date
01-12-2000
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2000
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar-2000-66811

Other articles of this Issue 1/2000

Arthritis Research & Therapy 1/2000 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine